The SARS-CoV-2 is a new emerging coronavirus that has not been previously identified in humans. Outbreak of this novel coronaviruses infections among people has raised widespread attention. Treatment with RNA polymerase inhibitors is one way to help stop the virus from replicating and control the infection. Creative Biolabs provides RNA polymerase inhibitors development services for the treatment of SARS-CoV-2. Our staff has decades of experience in anti-coronaviruses drug discovery, providing high-quality, efficient and cost-effective services. RNA Synthesis Inhibitors for Treatment of COVID-19 https://sars-cov-2.creative-biolabs.com/rna-synthesis-inhibitors-for-the-treatment-of-sars-cov2.htm